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ABSTRACT
The objectives of this study were to assess the as-
sociation of a 4-point scale of vaginal discharge score 
(VDS) with time to pregnancy to define criteria for a 
practical case of purulent vaginal discharge (PVD) in 
dairy cows, to test the risk factors for PVD, and, finally, 
the effect of a dose of PGF2α on cure and reproductive 
performance. In experiment 1, grazing Holstein cows (n 
= 2,414) had their vaginal discharge scored at ~32 d in 
milk (DIM) on a 4-point scale, the effect of VDS on the 
hazard of pregnancy by 300 DIM was then assessed to 
derive a case definition of PVD. Risk factors for PVD 
and self-cure were also assessed. In experiment 2, graz-
ing Holstein cows (n = 6,326) from 5 herds were checked 
for PVD at ~30 DIM. Cows with PVD were assigned 
to receive one dose of 500 μg of PGF2α analog (Clopro-
stenol; Ciclase, Syntex SA, Buenos Aires, Argentina) 
per cow (odd ear tag number) or to remain untreated 
(even tag number). Cure was declared if cows presented 
clear normal vaginal discharge (VDS-0) at visit 2 (~62 
DIM). Data were analyzed with Cox’s regression and 
mixed logistic models. In experiment 1, cows with VDS 
≥1 had lower hazard of pregnancy and longer calving 
to pregnancy interval than cows with VDS-0. This find-
ing was not affected by the time at which the diagnosis 
was performed. Therefore, a cow ≥21 DIM and having 
VDS ≥1 was used to define a case of PVD. The odds of 
PVD were greater in primiparous cows compared with 
multiparous, in cows with abnormal calving compared 
with those with normal calving, and in those losing 
BCS peripartum. In experiment 2, PGF2α treatment 
tended to slightly increase the hazard of pregnancy 
(adjusted hazard ratio = 1.13). Conversely, PGF2α had 
no effect on the odds of cure of PVD [adjusted odds ra-
tio (AOR) = 1.19], pregnancy at first service (AOR = 
1.03), or pregnancy by 100 DIM (AOR = 0.89) or 200 
DIM (AOR = 1.27). In conclusion, cows with VDS ≥1 
can be considered to have PVD because of their lower 
hazard of pregnancy and longer calving to pregnancy 
interval (up to 48 d). Important risk factors are par-
ity, calving, and body condition score loss peripartum. 
Optimal time of diagnosis is ≥28 to 35 DIM because 
cows experience a high self-cure rate. Self-cure is also 
affected by parity, prepartum BCS, and VDS. Finally, 
as treatment with one dose of PGF2α had a small effect 
on the hazard of pregnancy and no effect on clinical 
cure, its therapeutic use in grazing dairy cows with 
PVD is not recommended.
Key words: dairy cow, purulent vaginal discharge, 
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INTRODUCTION
General consensus is that clinical endometritis (CE) 
has detrimental effects on reproductive performance of 
dairy cows (LeBlanc et al., 2002a; McDougall et al., 
2007; Runciman et al., 2008; Gautam et al., 2009; Du-
buc et al., 2010a, 2011b; Giuliodori et al., 2013a), but 
disease definition has varied among research groups. 
The first definition of CE based on its negative effect 
on reproductive performance was proposed by LeBlanc 
et al. (2002a). Those authors defined CE by the detec-
tion of a purulent or foul vaginal discharge, or cervical 
diameter >7.5 cm at ≥20 DIM, or muco-purulent dis-
charge at ≥26 DIM (LeBlanc et al., 2002a). Based on 
that research, a group of researchers set a definition of 
CE as the presence of purulent (>50% pus) discharge 
in the vagina at ≥21 DIM, or by a muco-purulent (ap-
prox. 50% pus, 50% mucus) discharge in the vagina 
at ≥26 DIM (Sheldon et al., 2006). The prevalence of 
Purulent vaginal discharge in grazing dairy cows: Risk factors, 
reproductive performance, and prostaglandin F2α treatment
M. J. Giuliodori,* M. Magnasco,† R. P. Magnasco,† I. M. Lacau-Mengido,‡ and R. L. de la Sota§#1
*Cátedra de Fisiología, Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata (FCV-UNLP), Calle 60 y 118, La Plata, B1900AVW, 
Argentina
†Estudio Magnasco, Canals, Córdoba, X2650BXC, Argentina
‡Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas (IByME-CONICET),  
Ciudad Autónoma de Buenos Aires, C1428ADN, Argentina
§Cátedra y Servicio de Reproducción, Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata. Calle 60 y 118, La Plata, B1900AVW, 
Argentina
#Consejo Nacional de Investigaciones Científicas y Técnicas (IByME-CONICET), Ciudad Autónoma de Buenos Aires, C1033AAJ, Argentina
 
Received April 27, 2016.
Accepted January 1, 2017.
1 Corresponding author: dairydoc82@gmail.com
3806 GIULIODORI ET AL.
Journal of Dairy Science Vol. 100 No. 5, 2017
CE ranges from 5 to over 30% in some herds (LeB-
lanc et al., 2002a; Mejía and Lacau-Mengido, 2005; 
McDougall et al., 2007; Giuliodori et al., 2013a). It 
has recently been proposed to rename CE as purulent 
vaginal discharge (PVD), given that up to one third 
of cows having PVD have no evidence of endometritis 
(low count of polymorphonuclear cells; Dubuc et al., 
2010a; Denis-Robichaud and Dubuc, 2015). In clinical 
practice, endometrial cytology is rarely evaluated, so 
no evidence exists as to whether cows had endometrial 
inflammation (i.e., endometritis). It is widely accepted 
that dystocia, stillbirth, retained placenta, and metritis 
are risk factors for PVD (Ghanem et al., 2002; LeBlanc 
et al., 2002a; Dubuc et al., 2010a; Gautam et al., 2010; 
Potter et al., 2010; Giuliodori et al., 2013a); another 
proposed risk factor is peripartum negative energy 
balance (NEB; Dubuc et al., 2010a; Kaufmann et al., 
2010a; Giuliodori et al., 2013a). Treatment has received 
a lot of attention in recent decades and is still a contro-
versial issue (Haimerl et al., 2012, 2013; Lefebvre and 
Stock, 2012). That controversy is mainly rooted in the 
fact that comparison among studies is difficult because 
of different case definitions, low numbers of cows per 
treatment, lack of negative controls, and treatment suc-
cess based on clinical cure instead of on reproductive 
performance (Lefebvre and Stock, 2012). 
Our hypotheses were that a modified 4-point scale 
of vaginal discharge score (VDS) is associated with 
reproductive performance of cows and can be used to 
define a case of PVD, that the lower the DIM at di-
agnosis the higher the prevalence of PVD, and that 
PGF2α treatment increases cure rate and reproductive 
performance of treated cows. Our objectives were to 
assess (1) a 4-point scale of VDS to diagnose PVD in 
grazing Holstein dairy cows based on the reproductive 
performance of the cows (i.e., time to pregnancy), (2) 
the risk factors for PVD, (3) the optimal time to diag-
nose PVD, (4) the self-cure rate during the postpartum 
period, and (5) the effect of PGF2α treatment on cure 
rate and reproductive performance of cows.
MATERIALS AND METHODS
Farm and Animal Management
The study involved 2 experiments that were con-
ducted in 6 commercial dairy herds (35°37′S, 61°22′W, 
Argentina) enrolling a total of 8,740 grazing Holstein 
cows. Experiment 1 (effect of VDS) was performed on a 
single farm in years 2005 and 2006 (n = 2,414), whereas 
experiment 2 (effect of PGF2α) was run on 5 farms (A, 
B, C, D, and E) in years 2007 and 2008, enrolling a 
total of 6,326 cows (n = 936, 472, 2,386, 1,516, and 
1,016 cows for farms A through E, respectively). On 
all farms, prepartum cows that were within 4 wk of 
expected calving were maintained on dry lots, fed a 
low-DCAD diet, and monitored for signs of calving 
by farm employees trained to assist parturition. After 
calving, cows were sent for 3 d to the fresh herd and 
kept on a dry lot. Lactating cows were at pasture in a 
rotational system (different paddock in each morning 
and afternoon). Feed was composed of mixed pastures 
(alfalfa, tall fescue) and winter annual grasses (rye-
grass) and supplemented with TMR diets (corn silage, 
soybean pellets, and corn meal). Concentrates (40% 
soybean pellets and 60% corn meal) were offered twice 
daily during milking. The cows calved year-round and 
were milked twice daily with a herd average 305-d milk 
yield between 8,000 and 10,000 kg/cow. After a vol-
untary waiting period of 50 d, cows were observed for 
estrus twice daily and AI by using the a.m./p.m. rule. 
Pregnancy was diagnosed by rectal palpation after 35 d 
postinsemination, and pregnant cows were rechecked by 
transrectal palpation at 150 d of gestation. Veterinar-
ians visited the farms monthly for routine reproductive 
examination.
Vaginal Discharge Evaluation and Treatments
Experiment 1 (Effect of VDS). Cows had their 
vaginal discharge scored twice, at visits 1 [32 (21–49) 
DIM; median (highest–lowest)] and 2 [62 (48–97) DIM], 
by direct inspection after manual examination of the 
vagina with a gloved hand (Sheldon et al., 2002). 
Samples were scored on a 4-point scale as VDS-0 = 
clear discharge; VDS-1 = clear discharge with flecks of 
pus; VDS-2 = muco-purulent not fetid discharge; and 
VDS-3 = watery, purulent or brown-colored, fetid dis-
charge. In addition, body condition was scored (5-point 
scale; Ferguson et al., 1994) at each visit. As cows with 
VDS-1 and 2 at visit 1 were not treated, they were 
classified as self-cured if they had a VDS-0 at recheck 
at visit 2. Reproductive data were obtained from dairy 
records and used to assess the relationship between 
VDS and reproductive performance. Cows having VDS-
3 were excluded from the statistical analysis assessing 
reproductive performance because they received 12 g 
of oxytetracycline systemically (Terramicina LA, Pfizer 
SRL, Buenos Aires, Argentina) plus 750 μg of Tiaprost 
(Ileren, Intervet Argentina, Buenos Aires, Argentina).
Experiment 2 (Effect of PGF2α). Cows also 
had their vaginal discharge sampled twice and scored 
as previously described at visits 1 [30 (21–50) DIM; 
median (highest–lowest)] and 2 [58 (49–84) DIM]. Pu-
rulent vaginal discharge was diagnosed when cows had 
VDS-1 to 3 at visit 1, whereas cows with VDS-0 were 
considered as healthy. Cows having a VDS-1 and 2 at 
visit 1 were assigned by ear tag number to receive one 
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i.m. injection of 500 μg of cloprostenol (Ciclase, Syntex 
SA, Buenos Aires, Argentina) per cow (PGF2α group, 
odd tag number) or to remain untreated (control group, 
even tag number). Cure was declared if cows presented 
VDS-0 at visit 2 (~28 d later). Cows having VDS-3 
were not included in the statistical analysis assessing 
PGF2α effects on reproductive performance and cure 
rate because they received antibiotics, as described for 
experiment 1.
Statistical Analysis
Statistical significance was set at P < 0.05 and a ten-
dency was set at P < 0.10. Proportional hazard models 
were analyzed with PROC PHREG (SAS, 2003), and 
logistic models were analyzed with PROC GLIMMIX 
(SAS, 2003) with binomial distributions and logit link 
functions. Modeling was performed by using a manual 
backward elimination method with an exclusion criteria 
set at P > 0.10, with the exception of VDS in experi-
ment 1 and PGF2α in experiment 2, which were forced 
to remain in models.
Defining PVD (Experiment 1). The effect of 
VDS [0 vs. 1 vs. 2 (cows having VDS-3 were excluded 
from analysis because they received antibiotics)] on 
the hazard of pregnancy by 300 DIM was evaluated 
by proportional hazard analysis, whereas the effect 
on the odds of pregnancy at first AI (PFAI), by 100 
DIM (P100), and by 200 DIM (P200) were assessed 
by logistic regression analysis. The proportional haz-
ard ratio model included the fixed effects of calving 
season [summer (December 21–March 21) vs. autumn 
(March 21–June 21) vs. winter (June 21–September 21) 
vs. spring (September 21–December 21)], parity (1 vs. 
≥2), calving [normal vs. abnormal (dystocia, retention 
of placenta, and dead calf)], prepartum BCS (<2.75 
vs. 2.75–3.25 vs. ≥3.50), postpartum BCS (<2.50 
vs. 2.50–2.75 vs. ≥3.00, visit 1), and BCS loss (BCS 
prepartum minus BCS at visit 1: loss vs. no change 
or gain), and their 2-way interactions with VDS. Year 
of calving was included under the strata option. Time 
intervals (median ± 95% CI) and survival function es-
timates were obtained from PROC LIFETEST (SAS, 
2003). Logistic models included the random effect of 
year of calving (2005 vs. 2006) and the same fixed ef-
fects already described.
Optimal Time to Diagnose PVD (Expeiment 
1). The logistic model assessing the risk for PVD in-
cluded the fixed effect of time at visit 1 (≤27 vs. 28 
to 34 vs. ≥35 DIM) together with all the random and 
fixed effects described for risk factors analysis. Then, 
2 proportional hazard models assessing the hazard of 
pregnancy by 300 DIM were run combining the effects 
of VDS (0, 1, or 2) and the time when diagnosis was 
performed (<28 vs. ≥28 DIM in model 1 and <35 vs. 
≥35 DIM in model 2) as fixed effects.
Self-Cure Rate (Experiment 1). The logistic 
model assessing the risk of self-cure included the same 
random and fixed effects described for risk factors 
analysis. Cows having VDS-0 and -3 were excluded 
from this analysis.
Risk Factors for PVD (Experiment 1). The 
logistic model assessing risk factors included the ran-
dom effect of year of calving (2005 vs. 2006), and the 
same fixed effects previously described (calving season, 
parity, calving, prepartum BCS, and BCS loss). Cows 
having VDS-3 were not excluded from this analysis.
PGF2α Treatment Effects (Experiment 2). The 
proportional hazard models assessing the hazard of 
pregnancy by 300 DIM included the fixed effects of 
calving season [summer (December 21–March 21) vs. 
autumn (March 21–June 21) vs. winter (June 21–Sep-
tember 21) vs. spring (September 21–December 21)], 
parity (1 vs. ≥2), calving [normal vs. abnormal (dysto-
cia, retention of placenta, and dead calf)], VDS (1 vs. 
2), PGF2α (yes vs. no), and their 2-way interactions. 
The effects of year of calving and farm were included 
under the strata option. Time intervals (median ± 95% 
CI) and survival function estimates were obtained from 
PROC LIFETEST (SAS, 2003). The logistic models 
assessing the effect of PGF2α treatment (yes vs. no) on 
cure rate and reproductive performance (i.e., odds of 
PFAI, P100, and P200) included the random effect of 
year of calving (2007 vs. 2008) and farm (A, B, C, D, 
and E), and the same fixed effects already described for 
the proportional hazards regression model. Cows hav-
ing VDS-0 and -3 were excluded from analysis because 
they were considered healthy (VDS-0) and did not re-
ceive PGF2α or were treated with systemic antibiotics 
(VDS-3), as previously described.
RESULTS
In experiment 1, the percentages of cows having VDS-
0, VDS-1, VDS-2, and VDS-3 at visit 1 were 80.4% 
(1,852/2,303), 10.3% (237/2,303), 7.8% (180/2,303), 
and 1.5% (34/2,303), respectively.
Defining PVD
In proportional hazards and logistic regression mod-
els, the hazard ratio and the odds ratio represent the in-
stant risk and the risk of event (i.e., pregnancy) relative 
to cows without the factors of interest. For example, in 
Table 1, a hazard ratio of 0.74 means that cows having 
a VDS-1 had a risk of pregnancy per day only 74% of 
that of cows with VDS-0, and that cows with VDS-2 
(hazard ratio of 0.57) had daily risk of pregnancy only 
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57% of that of cows showing VDS-0. Also, cows hav-
ing VDS-1 and VDS-2 took 19 and 48 d longer to get 
pregnant, respectively, than cows with VDS-0 (Table 1, 
Figure 1). In addition, VDS was negatively associated 
with the odds of pregnancy (P < 0.01, Table 1), given 
that the odds of P100 were lower in cows VDS-1 and 
VDS-2 [odds ratio (OR) = 0.71 and 0.35, respectively] 
than in cows having VDS-0, and that the odds of P200 
were also lower in cows with VDS-1 and VDS-2 (OR = 
0.60 and 0.38, respectively) compared with cows having 
VDS-0. Thus, cows having VDS-1 or higher had lower 
reproductive performance than their counterparts with 
VDS-0 (Table 1), a VDS ≥1 was used to define a case 
of PVD.
Optimal Time to Diagnose PVD
The DIM at diagnosis had an effect on the detection 
of PVD, given that the proportion of positive cows were 
32, 19, and 15% when the diagnosis was performed 21 to 
27 versus 28 to 34 versus ≥35 DIM. The odds of detect-
ing PVD were significantly higher in cows checked 21 
to 27 DIM (OR = 3.40, 95% CI = 2.51–4.11) or 28–34 
DIM (OR = 1.66, 95% CI = 1.23–2.25) compared with 
cows evaluated ≥35 DIM.
The hazard models of the combined effects of VDS 
(0, 1, and 2) and time at diagnosis [<28 vs. ≥28 DIM 
(model 1) and <35 vs. ≥35 DIM (model 2)] showed that 
cows having VDS-1 diagnosed <28 versus ≥28 DIM 
had 33 and 17% lower hazard of pregnancy, respective-
ly, than cows with VDS-0, and that cows with VDS-2 
detected <28 versus ≥28 DIM had 41 and 44% lower 
hazard of pregnancy, respectively, than cows with VDS-
0 (Table 2). In addition, cows having VDS-1 diagnosed 
<35 versus ≥35 DIM had 25 and 19% lower hazard 
of pregnancy, respectively, than cows with VDS-0, and 
cows with VDS-2 checked <35 versus ≥35 DIM had 
37 and 52.5% lower hazard of pregnancy, respectively, 
than cows with VDS-0 (Table 2).
Self-Cure Rate
The proportion of self-cured cows was 57% (188/330). 
Primiparous cows had higher odds of self-cure than 
multiparous [adjusted odds ratio (AOR) = 1.84, 95% 
CI = 1.13–3.02, P = 0.02] with 63 and 50% cured, 
respectively. Cows with VDS-1 had higher odds of self-
cure than those having VDS-2 (AOR = 2.24, 95% CI 
= 1.34–3.76, P = 0.01) with 63 and 50% cured, respec-
tively. Finally, the odds of self-cure were higher in cows 
diagnosed 21 to 27 DIM than in those assessed ≥35 
DIM (AOR = 2.05, 95% CI = 1.16–3.62). Conversely, 
self-cure was similar for those checked 28 to 34 DIM 
to cows diagnosed ≥35 DIM (AOR = 1.19, 95% CI = 
0.64–2.22).
Risk Factors
The odds of PVD were higher in cows calving in sum-
mer, winter, and spring than in autumn (P < 0.01, 
Table 3). Primiparous cows had much higher odds of 
PVD than multiparous ones (P < 0.01). Cows experi-
encing abnormal calving had greater odds of PVD than 
those with normal calving (P < 0.01, Table 3). In addi-
tion, the odds of PVD were higher in cows experiencing 
peripartum BCS loss (P = 0.01, Table 3).
Effect of PGF2α Treatment
In experiment 2, the percentages of cows hav-
ing VDS-0, VDS-1, VDS-2, and VDS-3 were 77.2% 
(4,092/5,300), 12.8% (679/5,300), 8.0% (424/5,300), 
and 2.0% (105/5,300), respectively. Purulent vaginal 
discharge was diagnosed in 22.7% (1,208/5,300) of cows. 
Cows having VDS-3 were excluded from the analysis 
because they received systemic antibiotic treatment, so 
that only cows with VDS-1 (n = 679) and VDS-2 (n = 
424) were enrolled in the PGF2α trial (n = 1,103).
The hazard of pregnancy up to 300 DIM was slightly 
higher in cows receiving PGF2α treatment than in un-
treated cows (HR = 1.13, P = 0.09, Table 4). Median 
(95% CI) time from calving to pregnancy was 130 (120–
137) and 128 (120–137) days for treated and untreated 
cows with PVD (P = 0.07). Treatment with PGF2α had 
no effect on the odds of cure of PVD (P = 0.26, Table 
4), with 74.3 and 70.9% cured for PGF2α and untreated 
control groups, respectively (Table 4). Treatment with 
PGF2α had no effect on the odds of PFAI (P = 0.86, 
Table 4), with 33.8 and 33.2% of treated and untreated 
cows pregnant, respectively. Treatment had no effect 
on the odds of P100 (P = 0.51, Table 4) due to the 
percentage of pregnant cows being 29.8 and 32.5% for 
treated and untreated cows, respectively. Treatment 
had no effect on the odds of P200 (P = 0.17, Table 4) 
because the percentage of pregnant cows was 77.2 and 
72.8% in treated versus untreated cows, respectively.
DISCUSSION
The objectives of our study were to assess a 4-point 
scale of VDS for diagnosis of PVD and its association 
with reproductive performance, the risk factors for 
PVD in grazing Holstein dairy cows, the optimal time 
to diagnose PVD, and the effect of PGF2α treatment 
of PVD.
Defining PVD
In agreement with our hypothesis, the 4-point scale 
of VDS is associated with reproductive performance. 
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Higher VDS was associated with reduced odds of 
pregnancy at first AI and longer time to pregnancy. 
Therefore, by using this 4-point scale of VDS, a case of 
PVD can be defined in cows ≥21 DIM having VDS-1 
to -3, because these scores are significantly associated 
with poorer reproductive performance. Previous stud-
ies have reported the detrimental effects of PVD on 
reproduction (Fourichon et al., 2000; LeBlanc et al., 
2002a; Williams et al., 2005; McDougall et al., 2007; 
Runciman et al., 2008; Gautam et al., 2009, 2010; 
Dubuc et al., 2010a, 2011b; Plöntzke et al., 2011; Gi-
uliodori et al., 2013a), and our data agree with the fact 
that reproductive performance varies with VDS. It is 
generally accepted that PVD could reduce reproductive 
performance by delaying return to cyclicity (Mateus 
et al., 2002); by reducing progesterone production by 
luteal cells (Williams et al., 2007); by disrupting the 
uterine environment (BonDurant, 1999), and, lastly, 
by impairing embryo development (Soto et al., 2003). 
Irrespective of the explanation for the reduced fertility, 
it is important to note that the increase in pus content 
in the exudate in the vagina, and also the presence of 
fetid odor, are associated with decreased reproductive 
performance.
By using this definition, the prevalence of PVD 
(19.6% in experiment 1 and 22.8% in experiment 2) 
at visit 1 were similar to those previously reported 
(Ghanem et al., 2002; LeBlanc et al., 2002a; Mejía and 
Lacau-Mengido, 2005; Gautam et al., 2010; Potter et 
al., 2010; Plöntzke et al., 2011; Giuliodori et al., 2013a).
Optimal Time of Diagnosis
In agreement with our hypothesis, the proportion 
of cows with PVD is affected by the time (DIM) at 
which diagnosis is performed. The earlier the diagnosis 
Figure 1. Effect of postpartum vaginal discharge score (VDS) on 
the hazard of pregnancy in grazing Holstein dairy cows (n = 1,945). 
VDS-0 = clear discharge, VDS-1 = clear discharge with pus flecks, 
VDS-2 = muco-purulent not fetid discharge, and VDS-3 = watery, 
purulent or brown-colored, and fetid vaginal discharge. Median (95% 
CI) days open were 99 (95–103) for cows with VDS-0 (n = 1,615), 118 
(101–127) for cows with VDS-1 (n = 194), and 147 (134–162) for cows 
with VDS-2 (n = 136) (Log-rank test, P < 0.01). Cows diagnosed <21 
DIM (n = 111), having VDS-3 (n = 34), culled (n = 255), and with 
missing data (n = 69) were removed from the statistical analysis as-
sessing the effect of PGF2α on cure rate and reproductive performance 
[2,414 – (111 + 34 + 255 + 69) = 1,945].
Table 2. The effect of vaginal discharge score and the time at diagnosis on the reproductive performance in grazing Holstein dairy cows (n = 
1,945)
VDS1 Time2 n
K-M survival3
 
Hazard of conception
Median 95% CI AHR4 95%CI P-value
VDS-0 ≥28 1,336 100 96–104 Referent  <0.01
 <28 279 91 87–103 1.07 0.95–1.24 0.23
VDS-1 ≥28 142 112.5 99–122 0.83 0.69–0.99 0.04
 <28 52 134 103–159 0.67 0.51–0.90 0.01
VDS-2 ≥28 85 148 130–165 0.56 0.44–0.71 <0.01
 <28 51 146 104–180 0.59 0.44–0.79 <0.01
VDS-0 ≥35 942 102 97–107 Referent  <0.01
 <35 673 94 89–100 1.14 1.03–1.26 0.01
VDS-1 ≥35 87 105 95–123 0.81 0.65–1.01 0.06
 <35 107 125 103–151 0.75 0.61–0.92 <0.01
VDS-2 ≥35 52 161 132–183 0.48 0.35–0.64 <0.01
 <35 84 146 115–154 0.63 0.50–0.79 <0.01
1Vaginal discharge score: VDS-0 = clear discharge, VDS-1 = clear discharge with pus flecks, VDS-2 = muco-purulent not fetid discharge (and 
VDS-3 = watery, purulent or brown-colored, and fetid vaginal discharge). Cows diagnosed <21 DIM (n = 111), having VDS-3 (n = 34), culled 
(n = 255), and with missing data (n = 69) were removed from the statistical analysis [2,414 – (111 + 34 + 255 + 69) = 1,945].
2Time at diagnosis (in DIM): before and after 28 DIM (model 1) and before and after 35 DIM (model 2). 
3K-M survival = Kaplan–Meier survival analysis.
4AHR = adjusted hazard ratios.
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is performed, the higher the proportion of cows that 
are test-positive. In the present work, the prevalence of 
PVD <28 DIM was double relative to ≥35 DIM (32 vs. 
15%, respectively). This finding is in agreement with 
a previous report showing higher odds of PVD when 
cows were examined less than approximately 30 DIM 
(LeBlanc et al., 2002a; Gautam et al., 2010). As PVD 
was defined as those VDS that predicted reduced haz-
ard of pregnancy, the combined effects of VDS and the 
time at which diagnosis was performed were examined 
for their associations with reproductive performance. 
Cows with VDS ≥1 had lower hazard of pregnancy and 
longer calving to pregnancy interval than cows with 
VDS-0 (Table 2). This finding was not affected by the 
time at which the diagnosis was performed (28 or 35 
DIM); therefore, a cow ≥21 DIM and having VDS ≥1 
was used to define a case of PVD.
Self-Cure
The observed high self-cure rate (57% in experiment 
1 and 71% in experiment 2) could be the main reason 
why diagnosis should not be done too early postpar-
tum. Some reports document spontaneous cure ranging 
from 63 to 77% (Gautam et al., 2010; Dubuc et al., 
2011b; Plöntzke et al., 2011; Giuliodori et al., 2013a), 
but others found much lower self-cure rates (Brick et 
al., 2012; Maquivar et al., 2015). In addition, VDS has 
an effect on self-cure: the higher the score, the lower 
the odds of self-cure. This is in agreement with previous 
reports showing lower odds of clinical cure in treated 
cows with higher VDS (Kaufmann et al., 2010b; Mc-
Dougall et al., 2013). Also, prepartum BCS could play 
a role in self-cure, given that cows having BCS 2.75 to 
3.25 tended to show a higher spontaneous healing rate 
than cows having BCS <2.75 or ≥3.5; therefore, BCS 
before parturition would be a risk factor for persistent 
PVD. Similar results were found by our research group 
in Holstein dairy cows with metritis (Giuliodori et al., 
2013b), where lower probability of cure was associated 
with prepartum BCS <2.75, low insulin, and high 
BHB plasma concentration. Heidarpour et al. (2012) 
reported lower BHB in cured cows 1 wk after therapy 
than in cows failing to respond to treatment of PVD. 
Thus, our work and previous work would suggest that 
NEB could have an effect not only on the odds of PVD 
but also on its cure.
Risk Factors
The odds of PVD were greater in grazing cows calv-
ing in spring, summer, and winter in primiparous cows 
and in those with abnormal calving. Direct seasonal 
effects have rarely been reported, and results depend 
mostly on geographic region and herd management. 
In a cold climate, with cows mostly housed in barns 
in Guelph, Canada, fall was the peak season for the 
incidence of PVD (Erb and Martin, 1978); however, 
Table 3. Risk factors for purulent vaginal discharge in grazing Holstein dairy cows (n = 2,303)1
Predictor
Incidence
 
Odds ratio of PVD2
% no./no. AOR3 95% CI P-value
Season4     0.07
 Summer 20.9 133/637 Referent   
 Autumn 15.6 121/774 0.64 0.45–0.91  
 Winter 22.9 96/420 0.96 0.65–1.42  
 Spring 21.4 101/472 0.94 0.66–1.34  
Parity    <0.01
 1 26.1 263/1,007 Referent   
 ≥2 14.5 188/1,296 0.38 0.30–0.50  
Calving    0.02
 Normal 16.6 265/1,597 Referent   
 Abnormal 26.4 186/706 1.38 1.05–1.81  
BCS loss5    <0.01 
 No 12.7 109/858 Referent  
 Yes 21.8 229/1,050 2.32 1.79–3.03  
1Cows diagnosed <21 DIM (n = 111) were removed from the statistical analysis (2,414 – 111 = 2,303).
2Purulent vaginal discharge (PVD): cows with VDS-1, -2 and -3 at visit 1 postpartum (approximately 32 DIM) 
were declared as having PVD (VDS-0 = clear discharge, VDS-1 = clear discharge with pus flecks, VDS-2 = 
muco-purulent not fetid discharge, and VDS-3 = watery, purulent or brown-colored, and fetid vaginal dis-
charge).
3AOR = adjusted odds ratios.
4Season = calving season (summer vs. fall vs. winter vs. spring).
5BCS loss = prepartum BCS minus BCS at visit 1 postpartum (loss: no vs. yes). There were 113 cows with 
missing data regarding BCS pre- and postpartum.
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in our study, with temperate climate conditions and 
under an outdoor grazing system, the lowest incidence 
of PVD was recorded in fall. It has been reported that 
the risk for retained placenta increases during Spring 
and Summer (Faye et al., 1986), and as this disease has 
been related to PVD (LeBlanc et al., 2002a; Sheldon et 
al., 2009), which could help to explain the higher preva-
lence observed for cows that calved in the hot season. 
Greater odds for PVD observed in primiparous cows 
and in cows with abnormal calving is in agreement with 
previous reports (Ghanem et al., 2002; LeBlanc et al., 
2002a; Dubuc et al., 2010a; Gautam et al., 2010; Potter 
et al., 2010; Giuliodori et al., 2013a), and the explana-
tion might be that primiparity, and especially dystocia, 
which increases the possibility of trauma, tissue dam-
age, and bacterial contamination, could be leading to 
PVD (Sheldon et al., 2009). The odds of PVD are also 
affected by BCS loss peripartum given that cows los-
ing BCS have higher odds for this disease than their 
counterparts maintaining or gaining BCS. This finding 
is in agreement with a previous report showing that 
that prepartum fatty acids and BHB are associated 
with increased odds of PVD (Dubuc et al., 2010b; 
Kaufmann et al., 2010a; Giuliodori et al., 2013a). Also, 
a recent report documents a negative association be-
tween prepartum BCS and PVD (Kadivar et al., 2014). 
Our results also support previous studies showing low 
BCS at wk −6, 0, 4, and 10 relative to parturition is 
associated with increased odds of PVD (Hoedemaker 
et al., 2009). Thus, cows experiencing peripartum 
BCS loss, high fatty acids prepartum, and high BHB 
postpartum, indicative of severe NEB or unsuccessful 
adaptation to NEB, might be reflecting a decrease in 
DMI at that time (Bell, 1995). In this regard, there is a 
probable link between peripartal metabolic changes in 
the dairy cow and immunosuppression (Williams, 2013; 
Ingvartsen and Moyes, 2015); for example, it has been 
proposed that NEB may have a detrimental effect on 
neutrophil functions and, therefore, on uterine health 
leading to PVD (Hammon et al., 2006), and that deep 
NEB can be associated with the increased expression of 
inflammatory genes in the endometrium of postpartum 
cows (Wathes et al., 2009). Thus, our findings show 
that primiparity, abnormal calving, and loss of BCS 
peripartum are all associated with the odds of PVD 
in grazing dairy cows in temperate climate conditions.
Effect of PGF2α
In disagreement with our hypothesis, PGF2α had a 
tendency to slightly increase the hazard of pregnancy, 
but it had no effect on the odds of pregnancy by 100 and 
200 DIM or of cure of PVD. Our data support the con-
clusion of meta-analysis studies failing to find any evi-
dence of improvement in the reproductive performance 
of cows with PVD after treatment with PGF2α (Haim-
erl et al., 2012, 2013; Lefebvre and Stock, 2012). It was 
proposed that inducing estrus with PGF2α should clear 
the uterus and improve uterine health (Kasimanickam 
et al., 2005). Our study was not designed to test the 
effect of inducing estrus with PGF2α, but other studies 
also failed to find any benefit after a single injection 
of PGF2α (LeBlanc et al., 2002b), after 2 injections of 
PGF2α in cows with PVD (Dubuc et al., 2011b), or even 
following 3 injections of PGF2α given every other week 
in cows with subclinical endometritis (Galvão et al., 
2009). Additionally, detrimental effects of PGF2α treat-
ment on PFAI in cows without a corpus luteum have 
previously been reported by other researchers in some 
studies (LeBlanc et al., 2002b; Dubuc et al., 2011b) and 
by our group (Mejía and Lacau-Mengido, 2005). Thus, 
as no clear evidence exists of a positive effect of PGF2α 
on reproductive performance in grazing Holstein cows, 
the use of one dose of PGF2α for the treatment of PVD 
is not supported by our results or others.
CONCLUSIONS
In conclusion, PVD can be diagnosed in cows hav-
ing pus in their vaginal discharge (VDS-1 to VDS-3) 
≥21 DIM, given that VDS ≥1 is associated with lower 
hazard of pregnancy and longer calving to pregnancy 
interval (up to 48 d). Risk factors of PVD in graz-
ing dairy cows are calving season, calving problems, 
and BCS loss. In addition, diagnosis of PVD should 
not be performed before 28 to 35 DIM because cows 
experience a high self-cure rate. Finally, as 1 dose of 
a PGF2α analog (cloprostenol) had a negligible effect 
on the reproductive performance of grazing dairy cows 
with PVD, and no effect on the cure of PVD, we do not 
recommend the therapeutic use of 1 dose of PGF2α in 
postpartum grazing dairy cows having PVD.
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